Article
UBS Maintains Buy on Ovintiv, Raises Price Target to $61
UBS analyst Josh Silverstein maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $58 to $61.
Comments
- No comments yet. Be the first to comment!